chrisvoncsefalvay/vaers-outcomes huggingface dataset:
LOCAL TITLE: EMERGENCY                                           STANDARD TITLE: EMERGENCY MEDICINE NOTE                          DATE OF NOTE: JAN 11, 2022@13:34     ENTRY DATE: JAN 11, 2022@13:34:49                       EXP COSIGNER:                                 URGENCY:                            STATUS: COMPLETED                          *** EMERGENCY Has ADDENDA ***  ER Triage Note   Patient a 29 year old FEMALE presents to local Emergency   Department on 01/11/22 13:24.       Tetanus status: Last Tdap: Jan 26, 2017      LMP: 09-Jan-2022    Chief Complaint: Visit CC: Covid, hypoxia .     Informant:Self   Mode of Arrival:EMS   LOCAL TITLE: HCF_RN ADMISSION ASSESSMENT                         STANDARD TITLE: RN INPATIENT ADMISSION EVALUATION NOTE           DATE OF NOTE: JAN 11, 2022@20:00     ENTRY DATE: JAN 12, 2022@02:18:49                  EXP COSIGNER:                                 URGENCY:                            STATUS: COMPLETED                         Date and Time of Arrival: 11-Jan-2022 19:51   Diagnosis:  COVID, hypoxia, alcohol abuse history   Mode of Arrival: Wheelchair   Admitted From: ER   Patient is being discharged from local HOSPITAL Family  Care Unit today JAN 16, 2022.
1st dose1/11/21  nothing 2nd dose 2/8/21 achy with fatigue 3rd dose 10/22/21 achy, fatigue, fever which has persisted; still feeling fatigue and muscle aches and low dose fever ( accelerated on 11/7 up to 102 temperature/decreased to 99.5 now, but still fatigued and achy11
Extreme hoarseness; This is a spontaneous report from a contactable consumer (patient's child). A 90-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration on the left arm on 27Feb2021 12:00 (Batch/Lot number was not reported) at the age of 90 years old as 2nd dose, single for COVID-19 immunisation. Medical history included Chronic lymphocytic leukemia. The patient had no known allergies. Concomitant medications included vitamin B complex (VITAMIN B); omeprazole; and losartan potassium; all were reported as medications in two weeks. The patient previously had the first dose of BNT162B2, via an unspecified route of administration on the left arm on 30Jan2021 12:00 (Batch/lot number not reported) at the age of 90 years old as 1st dose, single for COVID-19 immunisation. The patient didn't have COVID prior to vaccination. The patient hadn't been tested post vaccination. On 28Feb2021 08:00 the patient experienced extreme hoarseness which resulted in doctor or other healthcare professional office/clinic visit. The patient didn't receive treatment for the event. The outcome of the event was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Pt came to pharmacy and asked me to look at his left arm. There was redness, pain and warm to touch. I told him to start ice on the area and take TYLENOL for pain. Also told him to see his Md. His MD gave him cefaclor 500 mg and Md told pt if not better he may have to go to the hospital.
Headache uterine cramping Narrative: Mild-Moderate Uterine Cramping (was 17 days away from next menstrual cycle)- lasted 20 minutes 2 Mild Headaches-lasted 20 minutes each
Pt was 15 years old at time of administration.  Third dose only approved for age 16 and over.
I got 3 shots but never went for the booster. Made me sick each time. Don't feel like being sick.; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult female patient received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "I got 3 shots but never went for the booster. Made me sick each time. Don't feel like being sick.".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After 1 st shot - about 3 days noticed tingling in face and felt tired.. but it only happened 2 times, both times I was coming out of hot tub.  After 2 shot, I noticed increasing feelings of weakness and feeling Short of breath.  Ended up in hospital ER 7/2 for low blood pressure and possible cardiac event
Low grade fever, headache, chills, sweating, dizziness, severe muscle aches, weakness, nausea, exhaustions, flu like symptoms, Severe itching and burning whole body by 6pm the day of injection -took 50 mg of Benadryl.  Tightness in chest and throat but could still breath.  Symptoms ran their course over 5 days.  Still struggling with muscle aches and nausea.
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Severe, Systemic: Headache-Medium, Systemic: Other- arm mobility limited/difficult 3 days, pain arm x 1 week bruising lasted 2 weeks
Systemic: See details below-Medium, Additional Details: Patient stated she is continueously having sore throat, allergy symptoms and, swellings on hands, fingers, and feet since next day of the vaccine administration. She tried several OTCs including Claritin, Benadryl, Tylenol, Aleve, sore throat spray, and Halls lozenges. None of those helps. She also takes HCTZ and will have PCP appt on 07/01/21. In the meantime, suggested her to discuss with PCP and withold the second dose until adverse reactions are being resolved.
Information has been received from a mother concerning her now 25 year old son who was vaccinated with MMR II as a child. The patient had "severe reactions" when he was got the vaccination. At that time, her son experienced fever, rashes and was "crabby like a bag of cats". The titer was drawn and showed he did not have rubella immunity. It was unknown if the patient sought medical attention. At the time of the reporting, the patient's status was unknown. No further information is available.
Swelling, COVID ARM, redness that spreads continuously days after injection, fever, soreness, tingling sensation at injection site, body aches, fatigue, cellulitis that needs to be treated with antibiotics
Patient complained of anxiety after taking vaccine. Denies SOB, dizziness, palpitations. Laid in stretcher for 15 min and stated anxiety decreased. Patient stable and released from vaccination site.
PT received Moderna Spikevax on 10/14 from our pharmacy. Pt called in on 10/18 to report the issue. The patient said that the vaccinating pharmacist had said that the initial needle that he was planning to use was too short, and that he was going to get a longer needle. Immediately after the vaccine was administered, the patient said "It hurt as bad as when I tore my rotator cuff." She reported asking the pharmacist about it being given too high, and they responded that it was given in the correct place. That whole day, the pain did not subside, and she was awake all night taking Tylenol and Advil for pain, but it has provided little to no help. She reports that she has been unable to move her arm/shoulder until today, but that the movement is still limited and painful.
Moderate nausea for 7 days post vaccine.  However, 7 days post vaccination, red, bumpy rash appeared just inferior to injection site; RT deltoid.  Warm and firm to the touch.  Measures 2.25" S/I  and 1.5" A/P.  It appears to be getting larger as of this evening. No longer individual bumps , more like wheals.   I have used a pen to draw around the perimeter to monitor progress. Also, 3/10/21, experienced left sided jaw pain.  No hx of TMJ disorder, ever!   Unable to open mouth fully and become concerning.  Fortunately, it resolved in less than 24 hrs.
Muscle spasms, twitching. Large lump at injection site, redness, painful. Unable to sleep, due to muscle spasms. Mild fever.
Armpit swelling to size of softball on arm of vaccination site; presumed to be lymph nodes; very painful (stayed swollen for nearly a week) Fatigue (for approx 4 days after onset) Joint aches and burning pain throughout body (hips, spine, feet in particular) for approx 36 hours upon onset. These are locations where psoriatic arthritis pain occurs at other times; this pain was intensified quite a lot in these 36 hours.   Right upper arm very sore around injection site for approx. 3 days Massive headache (for approx. 36 hours upon onset)  Chills (for approx. 24 hours upon onset) Fever (for approx. 12 hours upon onset)
Vomiting, diarrhea, intense fatigue, fever, chills, muscle pain, joint pain, headache, dizziness. Lasted 48 hours.
About 3 to 4 hours after receiving shot, patient had fever >102, Significant Chills, dizziness and unsteadiness when walking.  Pt took advil and went to lie down, and fell asleep.  In the morning, she felt weak, but improved, and no longer chilled . Patient did not seek medical attention, but was very concerned about such abad effect.
No adverse effects reported; Multiple patients were vaccinated with improperly stored VAQTA; This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's concurrent conditions and medical history, as well as concomitant medications, were not reported.  On 13-JUN-2019, the patient was vaccinated with an improperly stored dose of hepatitis a vaccine, inactivated (VAQTA) 25/0.5 (units not provided), lot # R018935, expiration date 05-SEP-2019, for prophylaxis (dose, route, anatomical site and frequency were not reported). The reporter stated that the vaccine had a temperature excursion of 34.2 F for 4 hours and 54 minutes, which was detected by a data logger. The vaccine had no previous temperature excursion and there were no adverse effects reported.  This is one of several cases from the same reporter.; Sender's Comments:  US-009507513-1907USA001174: US-009507513-1907USA004852: US-009507513-1907USA004853: US-009507513-1907USA004854: US-009507513-1907USA004855: US-009507513-1907USA004856: US-009507513-1907USA004857: US-009507513-1907USA004858: US-009507513-1907USA004859: US-009507513-1907USA004860: US-009507513-1907USA004861: US-009507513-1907USA004862: US-009507513-1907USA004863: US-009507513-1907USA004864: US-009507513-1907USA004865: US-009507513-1907USA004866: US-009507513-1907USA004867: US-009507513-1907USA004868: US-009507513-1907USA004869: US-009507513-1907USA004870: US-009507513-1907USA004871: US-009507513-1907USA004872: US-009507513-1907USA004873: US-009507513-1907USA004874: US-009507513-1907USA004875: US-009507513-1907USA004877: US-009507513-1907USA004878: US-009507513-1907USA004879: US-009507513-1907USA004880: US-009507513-1907USA004881: US-009507513-1907USA004882: US-009507513-1907USA004883: US-009507513-1907USA004884: US-009507513-1907USA004885: US-009507513-1907USA004886: US-009507513-1907USA004887: US-009507513-1907USA004888: US-009507513-1907USA004889: US-009507513-1907USA004890:
This non-serious spontaneous case, initially received from other health professional (nurse), on 12-Oct-2018, concerns a 37-year-old, adult female pregnant. On 10-Oct-2018, the pregnant patient received expired FLUCELVAX QIVc [batch number: 195215 and expiry date: 30-Apr-2018, dose, route of administration, anatomical location: not reported] (explicitly coded as expired vaccine exposure during pregnancy). At the time of this report, no adverse events were reported. Update received on 02-Nov-2018: Non-significant case correction (IRD: 12-Oct-2018): The case comment was corrected from " The company assessed the causality of the event expired vaccine used due to the accidental nature of the event" to "The company assessed the causality of the event expired vaccine uses as not related to suspect vaccine, due to the accidental nature of the event".
Severe vertigo, nausea, vomit, lightheadeness, brain fog, severe tinnitus, dizziness, chest pains, imbalance
Patient experienced chills, lethargy, and soreness the first couple days after administration. Patient stated that he started to have itchy skin on Monday (12/21) and now it looks like he has hives (redness and itchy) mostly on right arm, back, and chest. Patient has been using hydrocortisone. It was advised he take Benadryl orally to help with the hives.
Cellulitis secondary on (L) deltoid, given ROCEPHIN 1 gm 03/06/13.
Moderna 7/27/21, 8/24/21. Positive on 1/29/22
Received the vaccine on about March 17, 2021. She received her 2nd dose here on April 23rd  as  Vaccine. No issues reported with receiving the vaccine.
Information has been received from a physician, via a company representative, concerning an approximately 45 year old female, with an unknown medical history, who on 12-APR-2006 was vaccinated (route unknown) with a single dose of pneumococcal 23v polysaccharide vaccine (Lot#650649/0790P). Following the vaccination, on 12-APR-2006, the patient developed at the injection site, skin that was very hot, raised, blistered, painful and itchy.  Unspecified medical attention was sought.  Outcome was not reported.  No product quality complaint was involved.  Additional information has been requested.
Intense itching on arms,/face/back progressing to rash , then peeling of skin-cycle continued for 17 weeks.  not relieved by steroid dose pack x 2 and kenalog cream
Painful, raised rashes on body, angioedema.   Migraines, nausea without vomiting.  Pain radiating up spine, through both shoulders and neck, and into teeth.  Severe dizziness and vertigo.  Inability to control body temperature.  Symptoms almost identical to when I had COVID back in 11/20.  I have photo documentation of rashes and facial swelling should VAERS wish to see.
Information has been received from a nurse referring to an unknown number of patients of unknown age and gender. No relevant medical history or concurrent conditions were reported. On unknown dates these patients were vaccinated with improperly stored oral, ROTATEQ (lot # K016263, expiration date 26-JUN-2016; dose not reported). No adverse effect was reported. This one of several reports received from the same reporter. Additional information has been requested.
Originally had local reaction at site of administration of vaccine, red and itchy, resolving; but now reports a single "spot", tender to touch, slightly pink, non-vesicular, non-pustular on face, at jawbone.  Pt reported feeling generally itchy in am when she woke up, also thought there might have been 1 more pink spot on leg and another on back, but not present at 3:20 pm when she called me to report this problem.  Pt advised to show reaction to her primary care physician for evaluation, and will do so tomorrow.
Lost consciousness; A spontaneous report, was received from a pharmacist, concerning a patient of unknown age and gender, unknown race and ethnicity, who was administered Moderna's COVID-19 vaccine (mRNA-1273), and experienced loss of consciousness.  The patient's medical history was not provided. Concomitant medications were not reported.  On an unknown date, prior to the onset of the event, the patient received their unknown planned doses of mRNA-1273 (lot number: unknown), intramuscularly for the prophylaxis of COVID-19 infection.  On an unknown date, the pharmacist stated that they had a possible adverse reaction where patient lost consciousness shortly after receiving the vaccine. The patient was transported to the hospital by emergency medical services (EMS). Treatment information was not provided/unknown.     Action taken with mRNA-1273 in response to the event was not provided/unknown.   The outcome of the event, loss of consciousness, was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the event of loss of consciousness, a causal relationship cannot be excluded.
I had my vaccination on 10/03/2022. I started to experience coughing and fever on 12/26/2022. I tested COVID-19 positive on 12/27/2022. I was prescribed PAXLOVID. I currently feel fine with a residual cough on 01/10/2023.
Vaccinated approximately 5:15 pm on 9/21. Noticed unusual amount of soreness on Thurs morning (9/22). By Saturday 9/24 felt red, swollen, and hot on Sunday swelling had increased and redness spread over whole bicep area. Pt went to primary care and was given BACTRIM.
bloodclots in my leg and lungs; bloodclots in my leg and lungs; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown), single dose, dose 2 via an unspecified route of administration on 05Apr2021 for COVID-19 immunization. The patient's medical history was not reported. The patient's concomitant medications were not reported. The patient experienced blood clots in the leg and lungs in Apr2021 within days of receiving the second dose. The clinical outcome of blood clots in the leg and lungs were unknown.    Information on the lot/batch number has been requested.
This case was received by a health professional on 31 March 2008. A 42-year-old female patient, with an allergy to Amoxicillin, received a left deltoid booster injection of ADACEL (lot number C2767AA) on 25 March 2008. The patient was pregnant at the time of vaccination, and an ultrasound on 31 March 2008 showed a viable pregnancy with an estimated delivery date of 06 November 2008. Obstetric history included one previous pregnancy, which resulted in a pre-term delivery at six months; the baby expired due to unspecified chromosomal anomalies. No adverse events were reported following vaccination. Follow-up information received on 07 July 2008 from the original reporter who is a health care professional. The patient's obstetrical history was clarified, and the pre-term delivery at six months resulted in the baby expiring due to Trisomy 18 chromosomal abnormality. For the current pregnancy, the date of the patient's last menstrual period was on 01 January 2008; with an expected date of delivery on 12 November 2008. The patient had a mammogram completed on 25 March 2008 (results not reported). On 07 April 2008, the patient had an ultrasound that did not show a viable pregnancy. The patient was considered to have a spontaneous abortion prior to 20 weeks gestation as confirmed by ultrasound on 07 April 2008. The patient was healthy during the pregnancy. The recovery status of the patient was not provided. Due to this new information, this case was upgraded to serious.
Younger than 4 yo was administrated Kinrix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a patient who received DTPa-IPV (Kinrix) (batch number 2kl4k, expiry date 9th November 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 10-AUG-2022 Reporter's Comments: The medical assistance reported on 10th August 2022 that the patient younger than 4 years old was administrated with Kinrix.  No adverse event was reported. No patient's identifiers provided. No vaccination date provided. The reporter consented to follow up. Additional Supportive Information: The patient younger than 4 years old was administrated with Kinrix which led to inappropriate age at vaccine administration.
redness; swelling; Initial information was received on 06-Nov-2020 regarding an unsolicited valid non-serious case from a non-health care professional/consumer via sales representative.  This case involves a patient of unknown age who experienced redness (erythema) and swelling, when received INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [FLUBLOK QIV].  Medical history, past medical treatments, vaccinations and family history were not provided.  Concomitant medications were not reported.  On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE [batch number and expiration date not reported] via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient experienced redness (erythema) and swelling unknown latency following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE.  No laboratory data was reported.  It was not reported if the patient received any corrective treatment.  At the time of reporting, the patient was recovered from both the events on an unknown date.  There will be no information available regarding batch number in this case.
Extreme vertigo, included nausea, vomiting, dizziness and heavy sweating.  Lasted a few hours, another incidence on March 30.
Numbness in NON-vaccine arm that readiated to her neck/back. Red bumps (rash) that appears on the arms and burns, but then goes away. Very intense nerve pain.
2 hours after my first injection, I began to develop small hives along my abdomen. 2 weeks later this rash has spread all over my back and across my entire torso. Leading me to admit myself to the ER, where they gave me an IV of hydroxyzine & famotidine. The next day my rash was completely gone and I felt much better.
Patient given FLUMIST, then DTap injection. Within 2-3 minutes began to complain of not being able to breath through nose, crying loudly, then nose/mouth hurt, then rash/redness was evident over face, becoming clearly hives within 5 more minutes. She was given EPI 1:1000 (0.25 cc) immediately(and BENADRYL 25 mg po(by mouth). Hives were never hypotensive. SQ/IM gone within 10 minutes and she felt well.
Pt came to our office to recheck ears, following an ear infect pts ears were clear, t99 R; grandma gave pt APAP because pt seemed feverish; pt then recvd vax & had a febrile sz that noc; pt hospitalized for septic work-up, IV antibiotics
Warmth, redness, swelling, itching of entire (L) upper forearm.
Got shot at 12:45 pm and at 6 pm the night I started feeling a little cold and by 7 pm I was really cold with chills and a headache. It lasted 24 hours.
Immediate pain at site, large erythema at site within two hours, within five hours developed nausea with chills and headache (temp not taken), cough developed that night.
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 18-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator). On 18-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Administered vaccine after 33 days in the refrigerator) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment information was provided by the reporter.
11.5 hours after vaccine I began to vomit and continued for 48 hours with dry heaves. Only drank water then vomited . Ate 1/2 cut of chicken soup and vomited it up. Constant chills. Back ached so bad I couldn't sleep first 24 hours.  Still feel week 3 days later, however able to eat and drink with no nausea 1200 noon on 03/08/21.  No health issues, no medications.